+44 1223 790975
Research Contribution and Achievement
Conference Series LLC fosters research excellence and leadership by recognizing the outstanding researchers, exceptional graduates or early academicians who have distinctive enthrallment towards the conference themes. Nominees are judged on past accomplishments, research excellence and outstanding academic achievements. Researchers throughout the world who have been credited with outstanding achievements can make a significant contribution to the advancement of their field, thereby having a positive influence on the society.
To provide a strong professional development opportunity for early career academicians-meeting experts awards in different categories are announced such as Expert Level which will be presented to the expert researchers who have done exceptional work in the field of Emerging Diseases 2020. The award is considered the most distinguished award for who is passionate towards their work, willing to innovate and accept the aberrations happening in the research area with the introduction of recent trends. Followed by Professional Level which is termed as The Research Contribution Award for who should be hard working, diligent, focused and devoted to the specific field of interest. Next is the Scholar Level which will be presented to upcoming researchers and scientists in their respective field (Emerging Diseases 2020) who bring new technologies and innovations to their work according to the new trends in their field.
To encourage women scientists and researchers by providing a platform where they can present their work and passion towards their research Women Scientist Award will be presented which is also termed as The Women of Science Award. To acknowledge the speakers with great presentation skills, influential research work and long-term excellence Outstanding Speaker Award will be presented. Best Keynote Speaker Award will be presented to the keynote speaker who adds an extraordinary feel to the conference by their distinguished research work, projects and strategies that will provide a new trend in the field of Infectious and Rare Diseases.
Best Poster Presentation award will be presented to the research design which should be appropriate and transparent. Factual information should be kept separate from interpretations or implications. This award is given to encourage students and recent graduates to present their original research. The one who presents best thesis work will be awarded with Outstanding Masters/Ph.D./Post Doctorate thesis work which has been implemented to improve longterm excellence in the field of Emerging Diseases 2020.
These awards are a tribute to the men and women who have contributed to the progress of humanity through their dedication to science. Serving as a source of inspiration, the awards help to raise the profile of talented individuals in addition to the profession as a whole.
Emerging Diseases 2020 supported by the Speaker of renowned scientific and professional expert such as Reza Nassiri, Michigan State University, USA, it provided a platform for collaboration among colleagues, vendors, and academia to reveal new innovations, solutions, ideas, and emerging technologies in Infectious Diseases.
The global infectious disease market size was valued at USD 46.88 billion in 2017 and is projected to grow at a CAGR of 6.6% during the forecast period. Rising prevalence of infectious ailments, increasing expenditure to boost the penetration rate of treatments of these diseases, rising initiatives for creating awareness about treatments & diagnosis of these conditions, and increasing clinical test studies for development of latest drugs are likely to be the factors liable for growth of this market.
Increasing prevalence of Infectious, rising funding activities for patients suffering from Emerging, increasing supply of free HIV self-test kits in African countries, and rising awareness campaigns are the key factors responsible for the largest share held by this segment. In 2016, the HIV segment held the most important share i.e., 45.9% of the market.
In addition, WHO aims to check 90% and treat 80% of the people affected by HBV and HCV by 2025, through its Global Health Sector Strategy on hepatitis which is further expected to contribute to the growth of this segment.
Emerging Diseases Conferences going to be held during January 2020 to December 2020 at various cities in Europe (Barcelona, Madrid, Valencia, Rome, Berlin, Vienna, and Many More)
Program Manager | Emerging Diseases 2020
WhatsApp Number: +447426050685
Copyright: This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.